p2CT-His-MBP-Lwa_Cas13a_WT Citations (3)

Originally described in: RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
East-Seletsky A, O'Connell MR, Burstein D, Knott GJ, Doudna JA Mol Cell. 2017 May 4;66(3):373-383.e3. doi: 10.1016/j.molcel.2017.04.008. PubMed Journal

---

Articles Citing p2CT-His-MBP-Lwa_Cas13a_WT

Articles
CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells. Lin P, Qin S, Pu Q, Wang Z, Wu Q, Gao P, Schettler J, Guo K, Li R, Li G, Huang C, Wei Y, Gao GF, Jiang J, Wu M. Mol Cell. 2020 Jun 4;78(5):850-861.e5. doi: 10.1016/j.molcel.2020.03.033. Epub 2020 Apr 28. PubMed
Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms. Tian S, Liu Y, Appleton E, Wang H, Church GM, Dong M. Cell Rep. 2022 Mar 8;38(10):110476. doi: 10.1016/j.celrep.2022.110476. PubMed
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13. Lamothe G, Carbonneau J, Joly Beauparlant C, Vincent T, Quessy P, Guedon A, Kobinger G, Lemay JF, Boivin G, Droit A, Turgeon N, Tremblay JP. CRISPR J. 2023 Aug;6(4):369-385. doi: 10.1089/crispr.2023.0007. Epub 2023 Jun 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.